Chrysalix EVC | North AmericaChrysalix SET | EuropeChrysalix GRC | Asia

Developers of a low-cost, breakthrough solution for treating toxic organic pollutants in wastewater.

CHRYSALIX EVC FUND: CELP III
PORTFOLIO MANAGER: WAL VAN LIEROP
LOCATION: VANCOUVER, BC

 

Problem they are Solving:

Complex, expensive, and ineffective wastewater treatment systems.

Their Solution:

A low-cost, breakthrough solution for treating toxic organic pollutants in wastewater.

Why We invested: 

There is currently no cost-effective approach to treating recalcitrant organics in wastewater which create industrial operating bottlenecks due to equipment fouling. If resolved, industrial operators can achieve both operational savings and top-line growth.

Company’s Biggest Strength:

Despite having a clear technical path to a low-cost, reliable product, the biggest strength lays within the management team’s ability to partner and navigate the often difficult and fragmented wastewater space.

Implication When Successful:

Water security and re-use is a strategic issue for water-intensive industries. If Axine’s technology is successful, it stands to establish a new standard in wastewater treatment and help industrial customers everywhere improve the economics, efficiency, and effectiveness of their wastewater treatment.

CHRYSALIX EVC
Listen to Chrysalix Associate & Axine Board Observer, James Wells reflect on why the Firm invested in Axine.